Compare PSFE & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSFE | TOI |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United Kingdom | United States |
| Employees | 2900 | N/A |
| Industry | Business Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.7M | 327.6M |
| IPO Year | N/A | N/A |
| Metric | PSFE | TOI |
|---|---|---|
| Price | $7.18 | $3.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $8.69 | $6.67 |
| AVG Volume (30 Days) | 397.0K | ★ 2.1M |
| Earning Date | 03-03-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.26 | $27.81 |
| Revenue Next Year | $6.30 | $25.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $1.03 |
| 52 Week High | $18.15 | $4.88 |
| Indicator | PSFE | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 56.08 |
| Support Level | $6.61 | $3.22 |
| Resistance Level | $7.39 | $3.58 |
| Average True Range (ATR) | 0.35 | 0.31 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 39.47 | 53.90 |
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.